Evidence map›Paper›PMID 40076904›Full record

ArticleInternational journal of molecular sciences2025

Visualizing the Cellular and Subcellular Distribution of Fms-like Tyrosine Kinase 3 (Flt3) and Other Neuronal Proteins Using Alkaline Phosphatase (AP) Immunolabeling.

Yuqin Yin, Kathleen Z He, Jane Kirby, Ishraq A Haque, Xin Tang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuqin YinDepartment of Neurosurgery, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA.ORCID 0000-0002-0980-6954
Kathleen Z HeDepartment of Neurosurgery, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA.
Jane KirbyDepartment of Neurosurgery, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA.
Ishraq A HaqueHarvard College, Cambridge, MA 02138, USA.
Xin TangDepartment of Neurosurgery, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA.ORCID 0000-0003-2883-2610

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Molecular Pathways that Strengthen GABAergic Inhibition and Reduce Seizure SusceptibilityR01NS138758 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI Xin Tang · 2024 to 2026
$1.6M
Novel growth factors and regenerative RGC subtypes for optic nerve regenerationR21EY033550 · NEI · BOSTON CHILDREN'S HOSPITAL · PI YIN, YUQIN · 2023 to 2024
$487k
Shared High-resolution Laser Scanning Microscope with Airyscan 2S10OD030322 · OD · BOSTON CHILDREN'S HOSPITAL · PI CHEN, CHINFEI · 2022 to 2022
$476k
NEI NIH HHS R21 EY033550NICHD NIH HHS P50 HD105351NIH grant S10OD030322NIH HHS S10 OD030322NIH P50 HD105351NIH R01 R01NS138758NIH R21 R21EY033550NINDS NIH HHS R01 NS138758
6 · The paper itself

Abstract

Precisely localizing the spatial distribution of proteins within various brain cell types and subcellular compartments, such as the synapses, is essential for generating and testing hypotheses to elucidate their roles in brain function. While the fms-like tyrosine kinase-3 (Flt3) has been extensively studied in the context of blood cell development and leukemia pathogenesis, its role in the brain remains poorly understood. Previous efforts to address this issue were hindered by the low expression levels of Flt3 and the limited sensitivity of the standard immunolabeling method, which were insufficient to reliably detect Flt3 protein in brain tissue. In this study, we systematically characterized Flt3 protein localization during brain development using a highly sensitive immunolabeling method based on alkaline phosphatase (AP) polymer biochemistry. This approach revealed a previously unrecognized neuron-selective Flt3 expression pattern in both mouse and human cerebella, with a developmental increase in total protein levels accompanied by a shift from a cytosolic to a dendritic subcellular distribution. Combining AP-polymer-based immunohistochemistry (AP-IHC) for Flt3 with conventional immunostaining of cell type marker proteins revealed parvalbumin- and calbindin-positive Purkinje cells to be the main cell type expressing Flt3 in the cerebellum. To validate the versatility of the AP-IHC method for detecting low-abundance neuronal proteins, we demonstrated robust labeling of Kir2.1, a potassium channel protein, in brain tissue sections from mouse, pig, and human samples. We further applied the AP-IHC method to human stem cell-derived neurons, effectively visualizing the postsynaptic density scaffold protein PSD95 within synapses. To our knowledge, this is the first study to employ an AP-IHC method combined with other standard immunofluorescent staining to co-detect weakly expressed neuronal proteins and other cellular markers in brain tissue and cultured neurons. Additionally, our findings uncover a previously unrecognized neuron-specific pattern of Flt3 expression in the cerebellum, laying the foundation for future mechanistic studies on its role in normal brain development and neurological disorders.

Indexed as

Alkaline Phosphatasefms-Like Tyrosine Kinase 3Nerve Tissue ProteinsNeuronsAnimalsBrainCerebellumHumansImmunohistochemistryMiceMice, Inbred C57BLPurkinje CellsAlkaline PhosphataseFLT3 protein, humanfms-Like Tyrosine Kinase 3Nerve Tissue ProteinsAP-polymer histochemistrybrain developmentFlt3histochemistry and immunofluorescent co-staininghuman stem-cell derived neuronsKir2.1PSD95weakly expressed proteins

Identifiers

PMID40076904
PMCPMC11900488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.